A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies.

导出 LinkOut

翻译打印收藏纠错

作者： Anne-Marie,Chaftari ^[1] ; Ray,Hachem ^[1] ; Alexandre E,Malek ^[1] ; Victor E,Mulanovich ^[1] ; Ariel D,Szvalb ^[1] ; Ying,Jiang ^[1] ; Ying,Yuan ^[2] ; Shahnoor,Ali ^[1] ; Rita,Deeba ^[1] ; Patrick,Chaftari ^[3] ; Issam,Raad ^[1]

作者单位： Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[1] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[2] Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[3]

关键词 cancer patients febrile neutropenia fever immunocompromised leukemia neutropenia neutropenic fever

DOI 10.1093/ofid/ofac079

PMID 35663286

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Open forum infectious diseases

2022年9卷6期

ofac079页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

检索历史清除